Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

429066

Sigma-Aldrich

(3-Bromopropoxy)-tert-butyldimethylsilane

97%

Sinonimo/i:

(3-Bromopropoxy)(1,1-dimethylethyl)dimethylsilane, 1-((tert-Butyldimethylsilyl)oxy)-3-bromopropane, 1-Bromo-3-(tert-butyldimethylsiloxy)propane, 1-Bromo-3-[(tert-butyldimethylsilanyl)oxy]propane, 1-Bromo-3-[(tert-butyldimethylsilyl)oxy]propane, 3-((tert-Butyldimethylsilyl)oxy)-1-bromopropane

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula condensata:
Br(CH2)3OSi(CH3)2C(CH3)3
Numero CAS:
89031-84-5
Peso molecolare:
253.25
Numero MDL:
MFCD00216589
Codice UNSPSC:
12352100
ID PubChem:
24866833
NACRES:
NA.22

Saggio

97%

Forma fisica

liquid

contiene

sodium carbonate as stabilizer

Indice di rifrazione

n20/D 1.451 (lit.)

P. eboll.

182 °C (lit.)

Densità

1.093 g/mL at 25 °C (lit.)

Temperatura di conservazione

2-8°C

Stringa SMILE

CC(C)(C)[Si](C)(C)OCCCBr

InChI

1S/C9H21BrOSi/c1-9(2,3)12(4,5)11-8-6-7-10/h6-8H2,1-5H3
QGMROEZDWJTIDW-UHFFFAOYSA-N

Descrizione generale

(3-Bromopropoxy)-tert-butyldimethylsilane is a bromo silyl ether.

Applicazioni

(3-Bromopropoxy)-tert-butyldimethylsilane may be used to introduce propanol functionality to many pharmaceuticals.
It may be used as an alkylating agent in the synthesis of the following:
  • N-[2-[N-[3-(tert-butyldimethylsilyloxy)propyl]-N-ethylamino]ethyl]phthalimide
  • O-(3-tert-butyldimethylsilyloxypropyl)-N-(tert-butoxycarbonyl)-L-tyrosine methyl ester
  • tert-butyldimethyl-[3-(3-methyl-2-nitrophenoxy)propoxy]silane

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H315,H319,H335

Classi di pericolo

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Organi bersaglio

Respiratory system

Codice della classe di stoccaggio

10 - Combustible liquids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

185.0 °F - closed cup

Punto d’infiammabilità (°C)

85 °C - closed cup

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 5

1 of 5

p-Toluenesulfonyl fluoride 98%

Sigma-Aldrich

117455

p-Toluenesulfonyl fluoride

4-Chlorobenzyl bromide 97%

Sigma-Aldrich

558958

4-Chlorobenzyl bromide

2-Bromoethanol 95%

Sigma-Aldrich

B65586

2-Bromoethanol

tert-Butyldimethylsilyl chloride reagent grade, 97%

Sigma-Aldrich

190500

tert-Butyldimethylsilyl chloride

N,N-dimetilformammide anhydrous, 99.8%

Sigma-Aldrich

227056

N,N-dimetilformammide

A concise total synthesis of (+/-)-vigulariol.
J Stephen Clark et al.
Angewandte Chemie (International ed. in English), 46(3), 437-440 (2006-12-06)
Ramani R Ranatunge et al.
Journal of medicinal chemistry, 47(9), 2180-2193 (2004-04-16)
The synthesis of a series of novel pyrazoles containing a nitrate (ONO(2)) moiety as a nitric oxide (NO)-donor functionality is reported. Their COX-1 and COX-2 inhibitory activities in human whole blood are profiled. Our data demonstrate that pyrazole ring substituents
Margaret M Faul et al.
The Journal of organic chemistry, 69(9), 2967-2975 (2004-04-24)
Synthesis of indolo[6,7-a]pyrrolo[3,4-c]carbazoles 1, a new class of cyclin D1/CDK4 inhibitors, by oxidation of the corresponding aryl indolylmaleimides 2, will be described. Two approaches to the synthesis of 2 were identified that required new methods for the synthesis of 7-substituted
Mechanisms of ZnII-activated magnetic resonance imaging agents.
Major JL, et al.
Inorganic Chemistry, 47(22), 10788-10795 (2008)
Han-Cheng Zhang et al.
Bioorganic & medicinal chemistry letters, 14(12), 3245-3250 (2004-05-20)
A novel series of acyclic 3-(7-azaindolyl)-4-(aryl/heteroaryl)maleimides was synthesized and evaluated for activity against GSK-3beta and selectivity versus PKC-betaII, as well as a broad panel of protein kinases. Compounds 14 and 17c potently inhibited GSK-3beta (IC(50)=7 and 26 nM, respectively) and
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.